7 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... Inhibitors Oral ... P2Y12 inhibitors ... Switching Between Intravenous ... ticagrelor #prasugrel #pharmacology
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Antiplatelet Medications ... combination with P2Y12 ... the P2Y12 ADP receptor ... DrEricStrong #Antiplatelet ... Summary #Table #Pharmacology
Oral P2Y12 Inhibitor Pharmacology

 • Clopidogrel
 • Prasugrel
 • Ticagrelor

By Kyle Fischer, PharmD @Kfischer_10

#P2Y12 #Inhibitor #Pharmacology
Oral P2Y12 Inhibitor ... Pharmacology ... Kfischer_10 #P2Y12 ... #Inhibitor #Pharmacology
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Antiplatelet Conversion ... - P2Y12 Inhibitor ... @accpcardprn #Antiplatelet ... #Conversion #P2Y12 ... #pharmacology #
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... P2Y12 Inhibitors ... CIRCULATIONAHA.117.031164 #P2Y12 ... #Inhibitor #switching ... ticagrelor #prasugrel #pharmacology
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
with parenteral (intravenous ... heparin (UFH): Inhibits ... it to bind and inhibit ... anticoagulant that inhibits ... #Pharmacology #Pathophysiology
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
Cangrelor - Pharmacology ... pre-treated with an oral ... P2Y12 inhibitor ... No oral/enteral ... CABG) - As antiplatelet